Pfizer "Corona vaccine prevention rate 90%↑"... Application for emergency approval

<Anchor>

Pfizer, an American pharmaceutical company, announced the results of an interim analysis of phase 3 clinical trials that the COVID-19 vaccine, which is jointly developed with a German pharmaceutical company, showed more than 90% effectiveness.

Pfizer said it plans to apply for emergency vaccine approval later this month after safety testing has been completed.

Overnight, the New York and European markets surged at once.

The first news, Correspondent Kim Jong-won from New York reports.

<Reporter>

Pfizer, an American pharmaceutical company, announced an interim result of a phase 3 experiment involving 43,000 people from 5 countries around the world, and that the prevention rate of the COVID-19 vaccine under development by its company was over 90%.

Anthony Pouch, director of the National Institute of Allergy and Infectious Diseases of the United States, said that a corona vaccine prevention rate of only 50 to 60% is effective, far exceeding the 75% prevention rate expected by scientists so far.

This is close to twice the rate of protection against regular flu vaccines, with flu vaccines reducing your chances of getting a flu after vaccination by 40 to 60%.

According to Pfizer's announcement, the chance of getting corona is reduced by 90% after getting the corona vaccine currently being developed, which is similar to the measles vaccine.

[Albert Bulla/CEO of Pfizer: Based on these results, I think it is the greatest medical advancement in the history of 100 years.

The 90% prevention rate is a game-changing level.]

This announcement was made by the'Data Monitoring Committee', an independent external expert panel.

Pfizer plans to apply for emergency use approval from the Food and Drug Administration FDA about the following week after testing for vaccine safety.

As of yesterday (9th), the number of corona infections around the world was 54 million, with more than 10 million confirmed cases in the United States alone, the largest affected country.

With the announcement from Pfizer today, the New York stock market soared in unison, with the Dow index rising by more than 4% and the S&P 500 by nearly 3%.